跳至主要内容
临床试验/NCT02000310
NCT02000310Unknown不适用

Investigation of Molecular and Cellular Mechanisms of Lysosomal Storage Diseases

O & O Alpan LLC1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
Correlating genetic mutations with clinical signs and symptoms

研究概览

简要总结

The lysosome is a specialized part of the cell that functions to degrade metabolic wastes in the cell. Defects in the functioning of the lysosome result in accumulation and subsequent storage of such metabolic wastes. These defects lead to conditions known as lysosomal storage diseases (LSD). LSDs are caused by inherited genetic mutations and there are over 40 genetically distinct lysosomal storage diseases. Within each specific lysosomal storage disease there are variances in severity of disease, age of onset, and clinical presentation. Though the genetic mutations contributing to the disease have been largely clarified, the molecular and cellular mechanisms that contribute to variations in each distinct LSD remain unclear. With this study we intend to better understand at the cellular and molecular level how the accumulation and storage of metabolic wastes in the lysosome affect the clinical manifestation of LSDs, to detect changes in these mechanisms upon treatment administration, and to correlate these results to genetic information. The knowledge obtained from this research study could lead to better ways to diagnose and treat lysosomal storage diseases.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Day 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is greater than or equal to 1 day of age and less than or equal to 100 years of age
  • Signed Informed Consent/Assent
  • Subject is able and willing to comply with study protocol requirements.
  • From clinical or blood laboratory findings subject has evidence of a lysosomal storage disease or a family member of a patient with lysosomal storage disease

排除标准

  • Pregnant woman

结局指标

主要结局

Correlating genetic mutations with clinical signs and symptoms

时间窗: 5 years

Genetic information (DNA) will be collected from biological samples (e.g. blood, skin cells) and correlated with clinical signs and symptoms. DNA will be sequenced in order to identify a specific mutation. Fluorescence assay will be performed to measure the enzyme activity of the affected protein. Physical examination will be performed, and supporting test results will be collected for identifying the signs and symptoms of the particular disorder.

次要结局

  • Associated Immune Pathophysiology(5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验